A patient diagnosed with advanced pulmonary tuberculosis presents with anemia and an elevated erythrocyte sedimentation rate (ESR). Considering these findings, which nursing intervention should be prioritized to address the patient's immediate needs and prevent complications?

B) Monitor the patient's respiratory status and oxygen saturation closely.

A) Encourage the patient to increase iron-rich foods in their diet to address anemia.

B) Monitor the patient's respiratory status and oxygen saturation closely.

C) Educate the patient on the importance of medication adherence to the anti-tuberculosis regimen.

D) Schedule regular liver function tests to monitor for hepatotoxicity due to isoniazid therapy.

A patient has been diagnosed with advanced pulmonary tuberculosis, confirmed by positive AFB smear and culture, and is about to begin a multi-drug anti-tuberculosis regimen. Considering the patient's current health status, which nursing action is most critical in the initial management of this patient?

B) Initiate respiratory isolation measures to prevent the spread of infection to others.

A) Educate the patient on the importance of completing the full course of antibiotics to prevent drug resistance.

B) Initiate respiratory isolation measures to prevent the spread of infection to others.

C) Monitor liver function tests closely due to potential hepatotoxicity of tuberculosis medications.

D) Encourage a high-protein diet to address anemia and nutritional deficiencies.

A patient on an anti-tuberculosis treatment regimen is showing signs of clinical deterioration with increased fatigue, persistent fever, and a more pronounced cough with blood-streaked sputum. The chest X-ray indicates worsening infiltrates and the development of new cavitary lesions. What is the most appropriate initial nursing intervention to address the patient's hypoxemia?

A) Administer supplemental oxygen therapy

B) Increase fluid intake to help with sputum clearance

C) Encourage deep breathing exercises

D) Discontinue all antitubercular medications immediately

The patient undergoing treatment for tuberculosis is exhibiting signs of clinical deterioration, including increased fatigue, hemoptysis, and hypoxemia. Based on these findings, what is the most appropriate initial nursing intervention to address the patient's urgent needs?

A) Administer supplemental oxygen to improve oxygen saturation levels.

B) Discontinue all antitubercular medications immediately to prevent further liver damage.

C) Increase the frequency of chest physiotherapy to assist with airway clearance.

D) Encourage the patient to rest and increase fluid intake to manage fatigue.

A patient with progressive pulmonary tuberculosis and respiratory distress is being transferred to the ICU for closer monitoring. As part of the nursing care plan, what is the priority nursing intervention for this patient?

C) Assess respiratory status and prepare for possible therapeutic thoracentesis.

A) Administer a high-calorie, high-protein diet to address nutritional needs.

B) Monitor liver function tests closely due to the risk of hepatotoxicity from medications.

C) Assess respiratory status and prepare for possible therapeutic thoracentesis.

D) Educate the patient about the importance of adherence to the new medication regimen.

A patient with progressive pulmonary tuberculosis, receiving second-line antitubercular therapy, is transferred to the ICU due to increased respiratory distress and low oxygen saturation. Which nursing intervention is most appropriate to prioritize for this patient?

B) Prepare for potential therapeutic thoracentesis.

A) Initiate continuous positive airway pressure (CPAP) therapy.

B) Prepare for potential therapeutic thoracentesis.

C) Administer prescribed bronchodilators immediately.

D) Educate the patient about the importance of medication adherence.

A patient in the ICU with respiratory compromise and suspected tuberculosis has undergone thoracentesis, yielding straw-colored fluid. Despite interventions, the patient remains tachypneic with an oxygen saturation of 91%. Which nursing intervention should be prioritized to address the patient's current condition?

C) Monitor for signs of massive hemoptysis and prepare for potential intubation

A) Administer a bronchodilator to improve airway patency

B) Initiate high-calorie nutritional support to address anemia

C) Monitor for signs of massive hemoptysis and prepare for potential intubation

D) Adjust the antibiotic regimen based on pending sputum culture results

A patient in the ICU with suspected tuberculosis presents with decreased breath sounds, crackles in the lungs, and blood-streaked sputum. After a thoracentesis, their oxygen saturation improves to 91%. Which nursing intervention is most critical to prioritize in the care plan to manage the patient's respiratory status?

A) Encourage deep breathing and coughing exercises.

B) Administer prescribed bronchodilator therapy.

C) Position the patient in high Fowler's position.

D) Schedule regular incentive spirometry sessions.

A patient with confirmed pleural tuberculosis is experiencing elevated liver enzymes following initiation of anti-tuberculous therapy. The patient also demonstrates intermittent oxygen desaturation and increased respiratory distress. What is the most appropriate nursing intervention to address these concurrent issues?

A) Administer supplemental oxygen and notify the healthcare provider about the elevated liver enzymes.

B) Encourage deep breathing exercises and monitor liver function tests weekly.

C) Hold the current anti-tuberculous medications and prepare the patient for possible liver biopsy.

D) Increase the patient's fluid intake to promote liver detoxification and improve respiratory status.

A patient with confirmed Mycobacterium tuberculosis in pleural fluid is experiencing elevated liver enzymes due to anti-tuberculous medications. Which nursing intervention is most appropriate to support the patient's liver function while maintaining effective TB treatment?

C) Monitor liver function tests regularly and report significant changes.

A) Encourage a high-protein diet to support liver regeneration.

B) Administer all medications simultaneously to enhance compliance.

C) Monitor liver function tests regularly and report significant changes.

D) Increase the dosage of hepatotoxic drugs to ensure TB is treated aggressively.

tuberculosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Tuberculosis is caused by the inhalation of Mycobacterium tuberculosis bacteria, which primarily infects the lungs. The bacteria are engulfed by alveolar macrophages but can survive and replicate within these immune cells due to their waxy cell wall, which prevents lysosomal degradation.

• Secondary mechanism: The immune response forms granulomas, which are collections of immune cells that aim to contain the bacteria. While granulomas help localize the infection, they can also lead to tissue necrosis and cavitation in the lungs, impairing respiratory function.

• Key complication: If the immune system weakens, the bacteria can reactivate and spread, leading to miliary tuberculosis, which disseminates the infection to other organs, causing systemic complications such as meningitis or bone infections.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Diagnosed with latent tuberculosis infection 3 years ago; history of smoking (20 pack-years); hypertension

• Current medications: Isoniazid (for latent TB), Lisinopril (for hypertension)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and fever for the past 3 weeks

• Key symptoms: Night sweats, unintentional weight loss, fatigue, chest pain, hemoptysis

• Vital signs: Temperature 101.5°F, heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 138/88 mmHg

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team proceeded with a series of diagnostic tests to confirm the suspicion of active tuberculosis and assess the extent of the disease. A sputum sample was submitted for acid-fast bacilli (AFB) smear and culture, both of which returned positive, confirming the presence of Mycobacterium tuberculosis. Chest X-ray findings revealed bilateral upper lobe infiltrates with cavitary lesions, indicative of advanced pulmonary tuberculosis. Additionally, a CT scan of the chest provided further insight, showing extensive lung damage with multiple cavities and areas of consolidation, suggesting significant progression from the previously latent state.

The results of the complete blood count (CBC) showed anemia with a hemoglobin level of 10.5 g/dL, likely due to chronic disease and nutritional deficiencies secondary to weight loss. The erythrocyte sedimentation rate (ESR) was elevated at 85 mm/hr, reflecting an ongoing inflammatory process. Liver function tests were within normal limits, crucial for ongoing isoniazid therapy. The patient's HIV test returned negative, an important consideration as co-infection could complicate the clinical picture.

These findings emphasize the urgent need for a comprehensive treatment plan to address not only the active tuberculosis but also potential complications such as respiratory failure and further systemic spread. The multidisciplinary team, including infectious disease specialists and pulmonologists, must now consider the initiation of a multi-drug anti-tuberculosis regimen while monitoring for adverse reactions and signs of further complications. Heightened awareness and careful clinical reasoning are imperative as the patient navigates this critical phase of his treatment journey.

Section 2

Change in Patient Status:

Several weeks into the anti-tuberculosis treatment regimen, which included isoniazid, rifampicin, pyrazinamide, and ethambutol, the patient began to exhibit signs of clinical deterioration. During a routine follow-up visit, the patient reported increased fatigue, persistent low-grade fever, and a more pronounced cough producing blood-streaked sputum. Vital signs revealed a low-grade fever of 100.4°F, heart rate of 112 beats per minute, respiratory rate of 26 breaths per minute, and blood pressure slightly decreased at 98/62 mmHg. Oxygen saturation had also dropped to 88% on room air, prompting immediate concern for potential respiratory compromise.

A repeat chest X-ray indicated worsening infiltrates and the development of new cavitary lesions, suggesting progression of the disease despite adherence to treatment. Blood tests showed a further decline in hemoglobin levels to 9.8 g/dL, indicating worsening anemia, and liver function tests now revealed mild elevations in AST and ALT, raising concerns about hepatotoxicity from the medications. The elevated ESR remained consistent, underscoring the ongoing inflammatory response. Given these findings, the team considered the possibility of a multidrug-resistant TB strain or treatment failure due to malabsorption or drug interactions, necessitating a reevaluation of the treatment strategy.

In light of the patient's declining status, the interdisciplinary team prioritized the need for urgent adjustments to the management plan. This included temporarily adjusting the medication regimen to mitigate potential liver damage, introducing supplemental oxygen therapy to address hypoxemia, and considering the addition of second-line antitubercular agents. The patient was counseled on the importance of nutritional support to address anemia and support overall health. As the team worked to stabilize the patient, they remained vigilant for further complications, such as hemoptysis or respiratory failure, which would require prompt intervention.

Section 3

In response to the patient's declining status, the medical team initiated supplemental oxygen therapy and adjusted the anti-tuberculosis treatment regimen, temporarily holding isoniazid and pyrazinamide to mitigate potential hepatotoxicity. The patient was started on a high-calorie, high-protein diet, supplemented with iron and vitamins to address anemia and support overall recovery. Despite these interventions, the patient's status continued to pose challenges. During the next scheduled assessment, the patient exhibited increased respiratory distress, with a respiratory rate rising to 30 breaths per minute and oxygen saturation remaining critically low at 86% despite supplemental oxygen. The cough persisted, and the patient continued to produce blood-streaked sputum, raising concerns about potential hemoptysis.

A high-resolution CT scan of the chest was performed, revealing extensive bilateral cavitary lesions with areas of consolidation, consistent with progressive pulmonary tuberculosis. The scan also indicated early signs of pleural effusion, further complicating the respiratory status. Laboratory tests indicated a further drop in hemoglobin to 8.5 g/dL, and liver function tests showed progressive elevation of ALT and AST, necessitating a reevaluation of the hepatotoxic risk of the current regimen. A sputum culture was ordered to assess for multidrug-resistant TB, aiming to tailor the antibiotic regimen more effectively.

Given these findings, the team decided to initiate second-line antitubercular agents, including a fluoroquinolone and an aminoglycoside, while closely monitoring liver function. The patient was transferred to the ICU for closer monitoring and possible intervention, such as therapeutic thoracentesis, should the pleural effusion compromise respiratory function further. The interdisciplinary team remained alert to signs of acute complications, such as massive hemoptysis or acute respiratory failure, which would necessitate rapid intervention. As the patient began this intensified treatment plan, the team emphasized the importance of adherence to the new regimen and ongoing monitoring to optimize outcomes and prevent further deterioration.

Section 4

As the patient settled into the ICU, the medical team conducted a thorough initial assessment to establish a baseline for monitoring the response to the intensified treatment plan. Vital signs revealed a heart rate of 115 beats per minute, blood pressure at 98/64 mmHg, and persistent tachypnea with a respiratory rate of 32 breaths per minute. Despite high-flow oxygen therapy, the patient's oxygen saturation hovered around 88%, indicating significant respiratory compromise. Auscultation of the lungs revealed diminished breath sounds in the lower lobes, with crackles noted bilaterally, suggestive of fluid accumulation and consolidation. The patient's continued cough with blood-streaked sputum remained a concern, and the team reinforced the need for vigilant monitoring for any escalation to massive hemoptysis.

Laboratory tests returned further concerning results. The patient's hemoglobin had decreased slightly to 8.2 g/dL, reinforcing the need for ongoing nutritional support and consideration of potential blood transfusion if anemia worsened. Liver function tests indicated ALT and AST levels had risen to 200 U/L and 180 U/L, respectively, which necessitated a delicate balance in managing the hepatotoxicity risk while effectively treating the tuberculosis infection. The sputum culture was still pending, leaving the team to rely on empirical adjustments to the antibiotic regimen.

Amid these challenges, the team focused on optimizing the patient's respiratory status and addressing the pleural effusion. An ultrasound-guided thoracentesis was performed, yielding 500 mL of straw-colored fluid, which provided some relief in the patient's breathing and improved oxygen saturation to 91%. The fluid was sent for analysis to assess for TB infection and to guide further management. The patient's clinical status remained precarious, but these interventions offered a glimmer of stabilization, guiding the team to prioritize vigilant monitoring and timely adjustments to the treatment plan as they awaited culture results and further diagnostic insights.

Section 5

As the medical team continued to monitor the patient closely, new diagnostic results began to arrive, shedding light on the underlying complexities of the case. The analysis of the pleural fluid confirmed the presence of Mycobacterium tuberculosis, affirming the suspicion of pleural TB involvement. This finding necessitated a reevaluation of the current antibiotic regimen, emphasizing the need for a multidrug approach tailored to combat both the pulmonary and pleural manifestations of the disease effectively. Additionally, the acid-fast bacilli (AFB) smear from the initial sputum sample returned positive, underscoring the critical need for strict airborne precautions to prevent nosocomial transmission and protect both the patient and healthcare staff.

Meanwhile, the patient's liver function tests continued to show an upward trend, with ALT climbing to 250 U/L and AST to 230 U/L, raising concerns about potential drug-induced liver injury from the anti-tuberculous medications. The team faced a challenging dilemma: balancing the necessity for aggressive treatment of the TB infection with the risk of exacerbating hepatic dysfunction. A decision was made to consult with a hepatologist to explore strategies for hepatoprotection and consider alternative regimens that might mitigate hepatotoxicity while maintaining therapeutic efficacy.

In terms of clinical status, despite the initial improvement post-thoracentesis, the patient exhibited intermittent episodes of increased respiratory distress, with oxygen saturation occasionally dipping back to 89% during exertion. The persistent tachypnea and the patient's increasing fatigue prompted further investigations, including a repeat chest X-ray and consideration of advanced imaging to assess for any new complications such as pneumothorax or progression of pulmonary disease. This evolving scenario required the team to remain vigilant, prioritizing a multidisciplinary approach to adjust the treatment plan dynamically and ensure comprehensive care through these challenging developments.